Document Type : Letter(s) to the Editor
Authors
1 Clinical Medical College, School of Clinical Medicine, Dali University, Dali 671000, Yunnan, China
2 Gastrointestinal Surgery, Banan People’s Republic of Chongqing Medical University, Chongqing, Banan 401300, China
3 Department of Anesthesiology, Pingshan District Maternal and Child Healthcare Hospital of Shenzhen, Shenzhen, Guangdong, 518118, China
4 The Academy of Chinese Health Risks, West China Hospital, Sichuan University, Chengdu 610000, Sichuan, China
Abstract
Stroke, as the second leading cause of death and the third leading cause of disability worldwide, poses an
increasingly heavy disease burden.
Highlights
Cong Xu (Google Scholar)
Chaowen Chen (Google Scholar)
Keywords
Dear Editor
Stroke, as the second leading cause of death and the third leading cause of disability worldwide, poses an increasingly heavy disease burden. Between 1990 and 2019, global stroke incidence increased by 70%, the mortality rate increased by 43%, and disability-adjusted life years (DALYs) increased by 143%. Notably, 86% of stroke-related deaths and 89% of the DALYs were concentrated in low- and middle-income countries. 1 , 2
Recent studies have established that gut microbiota dysbiosis in stroke patients influences disease progression via the “microbiota-gut-brain axis”. This dysbiosis is characterized by a decrease in beneficial bacteria and an increase in pathogenic species, leading to the accumulation of pro-inflammatory metabolites and exacerbated neuroinflammation. While probiotic supplementation and dietary intervention indicated potential in modulating the microbiota and mitigating brain injury, clinical translation is challenged by individual variability. Future research should integrate multi-omics technologies to advance the development of precision treatments. 3 , 4 Due to the significance of this topic, this study addressed a current gap by conducting a comprehensive, global bibliometric analysis of research on stroke and gut microbiota. This study aimed to help researchers quickly grasp the knowledge structure, identify current research concerns, and generate novel research ideas.
We searched the Web of Science Core Collection database for literature related to stroke and gut microbiota from 2010 to 2024 using a structured search strategy. The search terms included “gut flora”, “gut microbiota”, and “gut microbiome”, combined with “stroke”. Using defined inclusion criteria, the selection was limited to original research articles published between January 2010 and December 2024, excluding reviews, conference papers, book chapters, and other non-article types. A total of 457 relevant articles were ultimately included for analysis.
This paper adopted bibliometric methods, utilizing VOSviewer (version 1.6.20; Centre for Science and Technology Studies, Leiden University, Netherlands) to visualize co-occurrence networks of countries and keywords. Concurrently, CiteSpace (version 6.3.R3, designed by Dr. Chaomei Chen, Drexel University, USA) was used to identify research frontiers and development trajectories through citation network analysis and cluster analysis. 5
Our analysis revealed a significant growth trend in this field. By formulating strict retrieval strategies and screening criteria, a total of 457 research papers were ultimately included, revealing a significant development trend in the field of stroke and gut microbiota research. The annual publication count increased from 1 in 2010 to 111 in 2024. This continuous growth reflects the academic community’s deepening interest in the role of the gut microbiota in stroke pathophysiology (figure 1).
Figure 1. The top 10 journals that published the most articles on stroke and gut microbiota (2010-2024).
Research on stroke and gut microbiota involved 46 countries and regions worldwide. This study identified the top 10 most prolific countries (table 1). Among them, China (n=278) ranked first in the number of published papers, followed by the United States (n=102) and Germany (n=20). Notably, China and the United States not only lead in output but also in academic influence, with cumulative citation frequencies of 5,670 and 14,510, respectively, far exceeding those of other countries. This data fully demonstrated the dominant position of the two countries in this research field and their broad international recognition in this field.
| Country | Documents | Citations | Total link strength |
|---|---|---|---|
| China | 278 | 5670 | 58695 |
| USA | 102 | 14510 | 44885 |
| Germany | 20 | 1506 | 12322 |
| Australia | 16 | 1284 | 8628 |
| Japan | 16 | 1118 | 4624 |
| England | 14 | 1618 | 8544 |
| South Korea | 13 | 258 | 5440 |
| Canada | 10 | 451 | 6383 |
| Poland | 9 | 76 | 2076 |
| Switzerland | 10 | 567 | 7073 |
Keyword cluster analysis identified eight main directions, including risk factors, dairy products, age-related neuropathy, reperfusion injury, ischemic stroke, gut microbiota, short-chain fatty acids, and the gut-brain axis. The co-occurrence analysis of high-frequency keywords—including “gut microbiota” (n=258), “stroke” (n=162), and “inflammation” (n=82)—highlighted current research hotspots. The trend indicated a shift from early risk factor analysis toward exploring deeper biological mechanisms, such as microbial metabolites and gut-brain axis signaling. A strong correlation was observed among clusters #2–5 (figures 2, 3, and table 2).
Figure 2. The figure shows the utilization of keywords by institutions across different years and keyword clustering analysis.
Figure 3. The diagram illustrates the co-citation relationships among keywords related to miRNA research in cervical cancer.
| Keyword | Occurrences | Total link |
|---|---|---|
| Gut microbiota | 258 | 929 |
| Stroke | 162 | 605 |
| Inflammation | 82 | 356 |
| Ischemic stroke | 80 | 296 |
| Metabolism | 64 | 279 |
| Microbiota | 63 | 255 |
| Risk | 58 | 247 |
| Disease | 52 | 238 |
| Phosphatidylcholine | 43 | 201 |
| Brain | 43 | 164 |
| Dysbiosis | 42 | 199 |
| Health | 36 | 141 |
| Atherosclerosis | 35 | 161 |
| Intestinal microbiota | 34 | 171 |
| Association | 34 | 149 |
| Obesity | 31 | 137 |
| Injury | 29 | 113 |
| Gut microbiome | 29 | 98 |
| Chain fatty-acids | 27 | 130 |
| Mice | 27 | 117 |
Recent years have seen substantial progress in understanding the role of gut microbiota in stroke pathophysiology. Research has elucidated the complex mechanisms by which the microbiota-gut-brain axis influences stroke onset and progression through neurological, endocrine, and immune pathways. Evidence indicates that gut microbiota-derived metabolites (such as short-chain fatty acids and secondary bile acids) can regulate intestinal barrier function and systemic immunity, and also directly affect brain function through pathways such as the vagus nerve. Dysregulation of this bidirectional network is closely linked to stroke risk and prognosis. 6 - 8
In summary, this bibliometric analysis reviewed research trends in stroke and gut microbiota from 2010 to 2024. By revealing a paradigm shift from risk factor association to mechanistic exploration, this study provided a foundation for the optimal allocation of research resources and for guiding future innovative breakthroughs.
Acknowledgment
This work was supported by the Dali City Industrial Information and Science and Technology Bureau on the Dali City 2024 Science and Technology Plan project (grant number: 2024KBG145); Scientific Research Fund Project of Yunnan Provincial Department of Education (grant number: 2025Y1140).
Authors’ Contribution
All authors contributed to the conception and design of the work, investigation, data interpretation, and drafting and reviewing the manuscript. C.C.: Supervised the project. All authors have read and approved the final manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Declaration of AI
The authors declare that no AI tools were used in the preparation of this manuscript.
Conflict of Interest
None declared.
References
- Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke. 2022; 17:18-29. DOI | PubMed
- Freburger JK, Pastva AM, Coleman SW, Peter KM, Kucharska-Newton AM, Johnson AM, et al. Skilled Nursing and Inpatient Rehabilitation Facility Use by Medicare Fee-for-Service Beneficiaries Discharged Home After a Stroke: Findings From the COMPASS Trial. Arch Phys Med Rehabil. 2022; 103:882-90. DOI | PubMed
- Wang JM, Yang MX, Wu QF, Chen J, Deng SF, Chen L, et al. Improvement of intestinal flora: accompany with the antihypertensive effect of electroacupuncture on stage 1 hypertension. Chin Med. 2021; 16:7. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
- Zhou J, Yang C, Lei W, Yang Z, Chen J, Lin H, et al. Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis. BMC Nephrol. 2022; 23:76. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
- van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84:523-38. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
- de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022; 71:1020-32. Publisher Full Text | DOI | PubMed [ PMC Free Article ]
- Lefort C, Cani PD. The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism. Cells. 2021; 10Publisher Full Text | DOI | PubMed [ PMC Free Article ]
- de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013; 17:657-69. Publisher Full Text | DOI | PubMed [ PMC Free Article ]